Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for MediWound (MDWD) over the last 11 years, with Q2 2025 value amounting to $5.6 million.

  • MediWound's Change in Acquisitions & Divestments rose 554.41% to $5.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$14.6 million, marking a year-over-year increase of 1002.52%. This contributed to the annual value of -$4.4 million for FY2024, which is 8531.74% up from last year.
  • Latest data reveals that MediWound reported Change in Acquisitions & Divestments of $5.6 million as of Q2 2025, which was up 554.41% from $5.3 million recorded in Q2 2024.
  • MediWound's Change in Acquisitions & Divestments' 5-year high stood at $5.6 million during Q2 2025, with a 5-year trough of -$25.6 million in Q2 2023.
  • In the last 4 years, MediWound's Change in Acquisitions & Divestments had a median value of $4.0 million in 2021 and averaged -$2.1 million.
  • In the last 5 years, MediWound's Change in Acquisitions & Divestments crashed by 10005.26% in 2021 and then soared by 12086.36% in 2024.
  • Over the past 4 years, MediWound's Change in Acquisitions & Divestments (Quarter) stood at -$4000.0 in 2021, then crashed by 639650.0% to -$25.6 million in 2023, then soared by 120.86% to $5.3 million in 2024, then grew by 5.54% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q2 2025, $5.3 million for Q2 2024, and -$25.6 million during Q2 2023.